|
시장보고서
상품코드
2132419
소프트젤 캡슐 시장 규모, 점유율, 동향 분석 보고서 : 종류별, 용도별, 최종 용도별, 지역별 및 부문별 예측(2026-2033년)Softgel Capsules Market Size, Share & Trends Analysis Report By Type, By Application, By End-use, By Region, And Segment Forecasts, 2026 - 2033 |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
소프트젤 캡슐 시장 요약
세계의 소프트젤 캡슐 시장 규모는 2025년에 85억 달러로 평가되며, 2026년 91억 달러에서 2033년까지 154억 달러로 확대될 것으로 예상되며, 2026년부터 2033년까지 연평균 성장률(CAGR)은 7.9%에 달할 것으로 예측됩니다.
북미가 시장을 주도하며, 2025년에는 세계 시장 점유율의 41.2%를 차지했습니다. 소프트젤 캡슐 시장은 제약, 영양 보충제 및 일반의약품(OTC) 업계의 수요 증가에 힘입어 꾸준한 성장을 이루고 있습니다.
영양 보충제, 예방 의료 제품 및 특수 경구 제제의 소비 증가에 따라 선진국 및 신흥 시장 전반에서 소프트젤 캡슐의 사용이 지속적으로 확대되고 있습니다. 제약사는 생체 이용률, 투여량의 정확성 및 제제의 안정성 향상이 요구되는 제품에서 소프트젤 제형의 채택을 확대하고 있습니다. 한편, 뉴트라슈티컬 기업들은 비타민, 미네랄, 오메가-3 보충제 및 허브 제제에 대한 소비자의 관심 증가에 부응하기 위해 제품 포트폴리오를 확충하고 있습니다.
제약 회사와 소비자 대상 헬스케어 기업이 생산 외주를 지속하는 가운데, 수탁 개발·제조 기관(CDMO)도 소프트젤 제조 역량 강화를 추진하고 있습니다. 또한, 각 제조사는 제조 효율을 높이고 변화하는 규제 및 소비자 요구 사항에 대응하기 위해 첨단 캡슐화 기술, 채식주의자용 캡슐 소재, 생산 자동화에 투자하고 있습니다. E-Commerce를 통한 유통 확대, 헬스케어 접근성 향상, 그리고 의약품 및 소비자용 헬스케어 분야의 지속적인 제품 혁신이 주요 지역 시장 전반에 걸쳐 이 시장의 성장을 뒷받침하고 있습니다.
자주 묻는 질문
목차
제1장 조사 방법과 범위
제2장 주요 요약
제3장 소프트젤 캡슐 시장 : 변수, 동향, 범위
제4장 소프트젤 캡슐 시장 : 유형별 비즈니스 분석
제5장 소프트젤 캡슐 시장 : 용도별 비즈니스 분석
제6장 소프트젤 캡슐 시장 : 최종 용도별 비즈니스 분석
제7장 소프트젤 캡슐 시장 : 지역별 추정·동향 분석
제8장 경쟁 구도
KSM 26.09.23Softgel Capsules Market Summary
The global softgel capsules market size was valued at USD 8.5 billion in 2025 and is projected to grow from USD 9.1 billion in 2026 to USD 15.4 billion by 2033, at a CAGR of 7.9% from 2026 to 2033. North America dominated the market, accounting for the largest global share of 41.2% in 2025. The softgel capsules market is experiencing steady growth, supported by increasing demand from the pharmaceutical, nutraceutical, and over-the-counter healthcare industries.
Rising consumption of dietary supplements, preventive healthcare products, and specialty oral formulations continues to expand the use of softgel capsules across developed and emerging markets. Pharmaceutical manufacturers are increasing the use of softgel dosage forms for products requiring improved bioavailability, dose accuracy, and formulation stability, while nutraceutical companies are expanding product portfolios to address growing consumer interest in vitamins, minerals, omega-3 supplements, and herbal formulations.
Contract development and manufacturing organizations are also strengthening softgel manufacturing capacity as pharmaceutical and consumer health companies continue to outsource production. In addition, manufacturers are investing in advanced encapsulation technologies, vegetarian capsule materials, and production automation to improve manufacturing efficiency and meet changing regulatory and consumer requirements. Growth in e-commerce distribution, expanding healthcare access, and continued product innovation across pharmaceutical and consumer health categories are supporting the market's development across major regional markets.
Global Softgel Capsules Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global softgel capsules market report based on type, application, end-use, and region:
- Type Outlook (Revenue, USD Million, 2021 - 2033)
- Gelatin-Based/Animal-Based
- Non-Animal-Based
- Application Outlook (Revenue, USD Million, 2021 - 2033)
- Antacid and Anti-Flatulent Preparation
- Anti-Anemic Preparations
- Anti-Inflammatory Drugs
- Antibiotic and Antibacterial Drugs
- Cough and Cold Preparations
- Health Supplement
- Vitamin and Dietary Supplement
- Pregnancy
- End Use Outlook (Revenue, USD Million, 2021 - 2033)
- Pharmaceutical Companies
- Nutraceutical Companies
- Cosmeceutical Companies
- Contract Manufacturing Organization
- Regional Outlook (Revenue, USD Million, 2021 - 2033)
- North America
- U.S.
- Canada
- Mexico
- Europe
- UK
- Germany
- France
- Italy
- Spain
- Denmark
- Sweden
- Norway
- Asia Pacific
- Japan
- China
- India
- Australia
- South Korea
- Thailand
- Latin America
- Brazil
- Argentina
- Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Segment Definitions
- 1.2.1. Type
- 1.2.2. Application
- 1.2.3. End-use
- 1.3. Estimates and Forecast Timeline
- 1.4. Research Methodology
- 1.5. Information Procurement
- 1.5.1. Purchased Database
- 1.5.2. GVR's Internal Database
- 1.5.3. Secondary Sources
- 1.5.4. Primary Research
- 1.6. Information Analysis
- 1.6.1. Data Analysis Models
- 1.7. Market Formulation & Data Visualization
- 1.8. Model Details
- 1.8.1. Commodity Flow Analysis
- 1.9. List of Secondary Sources
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Snapshot
- 2.2. Segment Snapshot
- 2.3. Competitive Landscape Snapshot
Chapter 3. Softgel Capsules Market Variables, Trends, & Scope
- 3.1. Market Lineage Outlook
- 3.2. Market Dynamics
- 3.2.1. Market Driver Analysis
- 3.2.2. Market Restraint Analysis
- 3.3. Business Environment Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
- 3.3.1.1. Supplier Power
- 3.3.1.2. Buyer Power
- 3.3.1.3. Substitution Threat
- 3.3.1.4. Threat of New Entrants
- 3.3.1.5. Competitive Rivalry
- 3.3.2. PESTLE Analysis
- 3.3.3. Pricing Analysis
- 3.3.1. Industry Analysis - Porter's Five Forces Analysis
Chapter 4. Softgel Capsules Market: Type Business Analysis
- 4.1. Type Market Share, 2025 & 2033
- 4.2. Type Segment Dashboard
- 4.3. Market Size & Forecasts and Trend Analysis, by Type, 2021 to 2033 (USD Million)
- 4.4. Gelatin-Based/Animal-Based
- 4.4.1. Gelatin-Based/Animal-Based Market, 2021 - 2033 (USD Million)
- 4.5. Non-Animal-Based
- 4.5.1. Non-Animal-Based Market, 2021 - 2033 (USD Million)
Chapter 5. Softgel Capsules Market: Application Business Analysis
- 5.1. Application Market Share, 2025 & 2033
- 5.2. Application Segment Dashboard
- 5.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
- 5.4. Antacid and Anti-Flatulent Preparation
- 5.4.1. Antacid and Anti-Flatulent Preparation, 2021 - 2033 (USD Million)
- 5.5. Anti-Anemic Preparations
- 5.5.1. Anti-Anemic Preparations Market, 2021 - 2033 (USD Million)
- 5.6. Anti-Inflammatory Drugs
- 5.6.1. Anti-Inflammatory Drugs Market, 2021 - 2033 (USD Million)
- 5.7. Antibiotic and Antibacterial Drugs
- 5.7.1. Antibiotic and Antibacterial Drugs Market, 2021 - 2033 (USD Million)
- 5.8. Cough and Cold Preparations
- 5.8.1. Cough and Cold Preparations Market, 2021 - 2033 (USD Million)
- 5.9. Health Supplement
- 5.9.1. Health Supplement Market, 2021 - 2033 (USD Million)
- 5.10. Vitamin and Dietary Supplement
- 5.10.1. Vitamin and Dietary Supplement Market, 2021 - 2033 (USD Million)
- 5.11. Pregnancy
- 5.11.1. Pregnancy Market, 2021 - 2033 (USD Million)
Chapter 6. Softgel Capsules Market: End Use Business Analysis
- 6.1. End Use Market Share, 2025 & 2033
- 6.2. End-use Segment Dashboard
- 6.3. Market Size & Forecasts and Trend Analysis, by End-use, 2021 to 2033 (USD Million)
- 6.4. Pharmaceutical Companies
- 6.4.1. Pharmaceutical Companies Market, 2021 - 2033 (USD Million)
- 6.5. Nutraceutical Companies
- 6.5.1. Nutraceutical Companies Market, 2021 - 2033 (USD Million)
- 6.6. Cosmeceutical Companies
- 6.6.1. Cosmeceutical Companies Market, 2021 - 2033 (USD Million)
- 6.7. Contract Manufacturing Organization
- 6.7.1. Contract Manufacturing Organization Market, 2021 - 2033 (USD Million)
Chapter 7. Softgel Capsules Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2025 & 2033
- 7.2. Regional Market Dashboard
- 7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
- 7.4. North America
- 7.4.1. North America Softgel Capsules Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key Country Dynamics
- 7.4.2.2. Target Disease Prevalence
- 7.4.2.3. Regulatory Framework
- 7.4.2.4. Reimbursement Framework
- 7.4.2.5. U.S. Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key Country Dynamics
- 7.4.3.2. Target Disease Prevalence
- 7.4.3.3. Regulatory Framework
- 7.4.3.4. Reimbursement Framework
- 7.4.3.5. Canada Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key Country Dynamics
- 7.4.4.2. Target Disease Prevalence
- 7.4.4.3. Regulatory Framework
- 7.4.4.4. Reimbursement Framework
- 7.4.4.5. Mexico Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5. Europe
- 7.5.1. Europe Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key Country Dynamics
- 7.5.2.2. Target Disease Prevalence
- 7.5.2.3. Regulatory Framework
- 7.5.2.4. Reimbursement Framework
- 7.5.2.5. UK Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key Country Dynamics
- 7.5.3.2. Target Disease Prevalence
- 7.5.3.3. Regulatory Framework
- 7.5.3.4. Reimbursement Framework
- 7.5.3.5. Germany Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key Country Dynamics
- 7.5.4.2. Target Disease Prevalence
- 7.5.4.3. Regulatory Framework
- 7.5.4.4. Reimbursement Framework
- 7.5.4.5. France Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key Country Dynamics
- 7.5.5.2. Target Disease Prevalence
- 7.5.5.3. Regulatory Framework
- 7.5.5.4. Reimbursement Framework
- 7.5.5.5. Italy Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key Country Dynamics
- 7.5.6.2. Target Disease Prevalence
- 7.5.6.3. Regulatory Framework
- 7.5.6.4. Reimbursement Framework
- 7.5.6.5. Spain Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.7. Denmark
- 7.5.7.1. Key Country Dynamics
- 7.5.7.2. Target Disease Prevalence
- 7.5.7.3. Regulatory Framework
- 7.5.7.4. Reimbursement Framework
- 7.5.7.5. Denmark Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key Country Dynamics
- 7.5.8.2. Target Disease Prevalence
- 7.5.8.3. Regulatory Framework
- 7.5.8.4. Reimbursement Framework
- 7.5.8.5. Sweden Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.5.9. Norway
- 7.5.9.1. Key Country Dynamics
- 7.5.9.2. Target Disease Prevalence
- 7.5.9.3. Regulatory Framework
- 7.5.9.4. Reimbursement Framework
- 7.5.9.5. Norway Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key Country Dynamics
- 7.6.2.2. Target Disease Prevalence
- 7.6.2.3. Regulatory Framework
- 7.6.2.4. Reimbursement Framework
- 7.6.2.5. Japan Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key Country Dynamics
- 7.6.3.2. Target Disease Prevalence
- 7.6.3.3. Regulatory Framework
- 7.6.3.4. Reimbursement Framework
- 7.6.3.5. China Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key Country Dynamics
- 7.6.4.2. Target Disease Prevalence
- 7.6.4.3. Regulatory Framework
- 7.6.4.4. Reimbursement Framework
- 7.6.4.5. India Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key Country Dynamics
- 7.6.5.2. Target Disease Prevalence
- 7.6.5.3. Regulatory Framework
- 7.6.5.4. Reimbursement Framework
- 7.6.5.5. Australia Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key Country Dynamics
- 7.6.6.2. Target Disease Prevalence
- 7.6.6.3. Regulatory Framework
- 7.6.6.4. Reimbursement Framework
- 7.6.6.5. South Korea Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key Country Dynamics
- 7.6.7.2. Target Disease Prevalence
- 7.6.7.3. Regulatory Framework
- 7.6.7.4. Reimbursement Framework
- 7.6.7.5. Thailand Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key Country Dynamics
- 7.7.2.2. Target Disease Prevalence
- 7.7.2.3. Regulatory Framework
- 7.7.2.4. Reimbursement Framework
- 7.7.2.5. Brazil Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key Country Dynamics
- 7.7.3.2. Target Disease Prevalence
- 7.7.3.3. Regulatory Framework
- 7.7.3.4. Reimbursement Framework
- 7.7.3.5. Argentina Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8. Middle East and Africa
- 7.8.1. Middle East and Africa Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key Country Dynamics
- 7.8.2.2. Target Disease Prevalence
- 7.8.2.3. Regulatory Framework
- 7.8.2.4. Reimbursement Framework
- 7.8.2.5. South Africa Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key Country Dynamics
- 7.8.3.2. Target Disease Prevalence
- 7.8.3.3. Regulatory Framework
- 7.8.3.4. Reimbursement Framework
- 7.8.3.5. Saudi Arabia Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key Country Dynamics
- 7.8.4.2. Target Disease Prevalence
- 7.8.4.3. Regulatory Framework
- 7.8.4.4. Reimbursement Framework
- 7.8.4.5. UAE Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key Country Dynamics
- 7.8.5.2. Target Disease Prevalence
- 7.8.5.3. Regulatory Framework
- 7.8.5.4. Reimbursement Framework
- 7.8.5.5. Kuwait Softgel Capsules Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Participant Overview
- 8.2. Company Market Position Analysis
- 8.3. Company Categorization
- 8.4. Strategy Mapping
- 8.5. Company Profiles/Listing
- 8.5.1. Fuji Capsule
- 8.5.1.1. Overview
- 8.5.1.2. Financial Performance
- 8.5.1.3. Product Benchmarking
- 8.5.1.4. Strategic Initiatives
- 8.5.2. Sirio Pharma Co., Ltd.
- 8.5.2.1. Overview
- 8.5.2.2. Financial Performance
- 8.5.2.3. Product Benchmarking
- 8.5.2.4. Strategic Initiatives
- 8.5.3. CAPTEK Softgel International Inc.
- 8.5.3.1. Overview
- 8.5.3.2. Financial Performance
- 8.5.3.3. Product Benchmarking
- 8.5.3.4. Strategic Initiatives
- 8.5.4. Thermo Fisher Scientific Inc.
- 8.5.4.1. Overview
- 8.5.4.2. Financial Performance
- 8.5.4.3. Product Benchmarking
- 8.5.4.4. Strategic Initiatives
- 8.5.5. EyePoint Pharmaceuticals, Inc.
- 8.5.5.1. Overview
- 8.5.5.2. Financial Performance
- 8.5.5.3. Product Benchmarking
- 8.5.5.4. Strategic Initiatives
- 8.5.6. Catalent, Inc.
- 8.5.6.1. Overview
- 8.5.6.2. Financial Performance
- 8.5.6.3. Product Benchmarking
- 8.5.6.4. Strategic Initiatives
- 8.5.7. EuroCaps
- 8.5.7.1. Overview
- 8.5.7.2. Financial Performance
- 8.5.7.3. Product Benchmarking
- 8.5.7.4. Strategic Initiatives
- 8.5.8. Aenova Group
- 8.5.8.1. Overview
- 8.5.8.2. Financial Performance
- 8.5.8.3. Product Benchmarking
- 8.5.8.4. Strategic Initiative
- 8.5.9. Lonza Capsules & Health Ingredients
- 8.5.9.1. Overview
- 8.5.9.2. Financial Performance
- 8.5.9.3. Product Benchmarking
- 8.5.9.4. Strategic Initiatives
- 8.5.10. ProCaps Laboratories, LLC
- 8.5.10.1. Overview
- 8.5.10.2. Financial Performance
- 8.5.10.3. Product Benchmarking
- 8.5.10.4. Strategic Initiatives
- 8.5.11. Soft Gel Technologies, Inc.
- 8.5.11.1. Overview
- 8.5.11.2. Financial Performance
- 8.5.11.3. Product Benchmarking
- 8.5.11.4. Strategic Initiatives
- 8.5.1. Fuji Capsule
